{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:34:13Z","timestamp":1782128053668,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,13]],"date-time":"2012-01-13T00:00:00Z","timestamp":1326412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s10461-011-0124-7","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T11:46:12Z","timestamp":1326714372000},"page":"142-147","source":"Crossref","is-referenced-by-count":77,"title":["Association Between Use of Specific Drugs and Antiretroviral Adherence: Findings from MACH 14"],"prefix":"10.1007","volume":"17","author":[{"given":"M. I.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Goggin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. H.","family":"Remien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. E.","family":"Golin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. R.","family":"Bangsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,13]]},"reference":[{"issue":"12","key":"124_CR1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1046\/j.1525-1497.2001.01025.x","volume":"16","author":"S Crystal","year":"2001","unstructured":"Crystal S, Sambamoorthi U, Moynihan PJ, McSpiritt E. Initiation and continuation of newer antiretroviral treatments among medicaid recipients with AIDS. J Gen Intern Med. 2001;16(12):850\u20139.","journal-title":"J Gen Intern Med"},{"issue":"9","key":"124_CR2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1525-1497.2001.016009625.x","volume":"16","author":"BJ Turner","year":"2001","unstructured":"Turner BJ, Fleishman JA, Wenger N, London AS, Burnam MA, Shapiro MF, et al. Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med. 2001;16(9):625\u201333.","journal-title":"J Gen Intern Med"},{"issue":"11","key":"124_CR3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/516778","volume":"44","author":"TP Giordano","year":"2007","unstructured":"Giordano TP, Gifford AL, White AC Jr, Suarez-Almazor ME, Rabeneck L, Hartman C, et al. Retention in care: a challenge to survival with HIV infection. Clin Infect Dis. 2007;44(11):1493\u20139.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"124_CR4","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/01.WNL.0000038347.48137.67","volume":"59","author":"CH Hinkin","year":"2002","unstructured":"Hinkin CH, Castellon SA, Durvasula RS, Hardy DJ, Lam MN, Mason KI, et al. Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology. 2002;59(12):1944\u201350.","journal-title":"Neurology"},{"issue":"1","key":"124_CR5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00126334-200401010-00006","volume":"35","author":"RD Moore","year":"2004","unstructured":"Moore RD, Keruly JC, Chaisson RE. Differences in HIV disease progression by injecting drug use in HIV-infected persons in care. J Acquir Immune Defic Syndr. 2004;35(1):46\u201351.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"124_CR6","doi-asserted-by":"crossref","first-page":"968","DOI":"10.7326\/0003-4819-134-10-200105150-00011","volume":"134","author":"H Liu","year":"2001","unstructured":"Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968\u201377.","journal-title":"Ann Intern Med"},{"issue":"1","key":"124_CR7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-133-1-200007040-00004","volume":"133","author":"DL Paterson","year":"2000","unstructured":"Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21\u201330.","journal-title":"Ann Intern Med"},{"issue":"3","key":"124_CR8","first-page":"15","volume":"31","author":"N Press","year":"2002","unstructured":"Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS. Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence. J Acquir Immune Defic Syndr. 2002;31(3):15.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"24","key":"124_CR9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1001\/jama.1996.03540240033024","volume":"276","author":"GF Vanhove","year":"1996","unstructured":"Vanhove GF, Schapiro JM, Winters MA, Merigan TC, Blaschke TF. Patient compliance and drug failure in protease inhibitor monotherapy. JAMA. 1996;276(24):1955\u20136.","journal-title":"JAMA"},{"issue":"7","key":"124_CR10","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/507526","volume":"43","author":"DR Bangsberg","year":"2006","unstructured":"Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939\u201341.","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"124_CR11","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1097\/00126334-200212153-00006","volume":"31","author":"CF Perno","year":"2002","unstructured":"Perno CF, Ceccherini-Silberstein F, De Luca A, Cozzi-Lepri A, Gori C, Cingolani A, et al. Virologic correlates of adherence to antiretroviral medications and therapeutic failure. J Acquir Immune Defic Syndr. 2002;31(Suppl 3):S118\u201322.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"124_CR12","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1360-0443.2008.02269.x","volume":"103","author":"M Malta","year":"2008","unstructured":"Malta M, Strathdee SA, Magnanini MMF, Bastos FI. Adherence to antiretroviral therapy for human immunodeficiency virus\/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242\u201357.","journal-title":"Addiction"},{"issue":"6","key":"124_CR13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003495-200666060-00004","volume":"66","author":"G Chander","year":"2006","unstructured":"Chander G, Himelhoch S, Moore RD, Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769\u201389.","journal-title":"Drugs"},{"issue":"5","key":"124_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11606-002-0044-3","volume":"17","author":"JH Arnsten","year":"2002","unstructured":"Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegan H, Howard AA, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17(5):377\u201381.","journal-title":"J Gen Intern Med"},{"key":"124_CR15","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/322590","volume":"33","author":"J McNabb","year":"2001","unstructured":"McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP. Adherence to Highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic. Clin Infect Dis. 2001;33:700\u20135.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"124_CR16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10461-006-9152-0","volume":"11","author":"CH Hinkin","year":"2007","unstructured":"Hinkin CH, Barclay TR, Castellon SA, Levine AJ, Durvasula RS, Marion SD, et al. Drug use and medication adherence among HIV-1 infected individuals. AIDS Behav. 2007;11(2):185\u201394.","journal-title":"AIDS Behav"},{"key":"124_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00002030-200401001-00004","volume":"18","author":"CH Hinkin","year":"2004","unstructured":"Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18:19\u201325.","journal-title":"AIDS"},{"issue":"4","key":"124_CR18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1310\/YVTR-T8EV-3TQ6-QAJC","volume":"4","author":"G Wagner","year":"2003","unstructured":"Wagner G. Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? HIV Clin Trials. 2003;4(4):269\u201381.","journal-title":"HIV Clin Trials"},{"issue":"10","key":"124_CR19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1046\/j.1525-1497.2002.11214.x","volume":"17","author":"C Golin","year":"2002","unstructured":"Golin C, Liu H, Hays R, Miller L, Beck C, Ickovics J, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med. 2002;17(10):756\u201365.","journal-title":"J Gen Intern Med"},{"issue":"16","key":"124_CR20","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/00002030-200211080-00010","volume":"16","author":"AA Howard","year":"2002","unstructured":"Howard AA, Arnsten JH, Lo Y, Vlahov D, Rich JD, Schuman P, et al. A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS. 2002;16(16):2175\u201382.","journal-title":"AIDS"},{"issue":"12","key":"124_CR21","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.addbeh.2007.04.006","volume":"32","author":"MJ Reinhard","year":"2007","unstructured":"Reinhard MJ, Hinkin CH, Barclay TR, Levine AJ, Marion S, Castellon SA, et al. Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. Addict Behav. 2007;32(12):2727\u201336.","journal-title":"Addict Behav"},{"issue":"2","key":"124_CR22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/QAI.0b013e3181b18b6e","volume":"52","author":"CS Hendershot","year":"2009","unstructured":"Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52(2):180\u2013202.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"124_CR23","unstructured":"Liu H, Wilson IB, Goggin K, Reynolds NR, Simoni JM, Golin CE, et al. MACH14: a multi-site collaboration on ART adherence among 14 institutions (Under Review)."},{"issue":"11","key":"124_CR24","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1525-1497.2004.30445.x","volume":"19","author":"KM Berg","year":"2004","unstructured":"Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med. 2004;19(11):1111\u20137.","journal-title":"J Gen Intern Med"},{"issue":"6","key":"124_CR25","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/09540120310001618621","volume":"15","author":"CJ Reback","year":"2003","unstructured":"Reback CJ, Larkins S, Shoptaw S. Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men. AIDS Care. 2003;15(6):775\u201385.","journal-title":"AIDS Care"},{"issue":"3","key":"124_CR26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00126334-200107010-00006","volume":"27","author":"GM Lucas","year":"2001","unstructured":"Lucas GM, Cheever LW, Chaisson RE, Moore RD. Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr. 2001;27(3):251\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"124_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1360-0443.2003.00310.x","volume":"98","author":"DH Epstein","year":"2003","unstructured":"Epstein DH, Preston KL. Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against. Addiction. 2003;98(3):269\u201379.","journal-title":"Addiction"},{"issue":"1","key":"124_CR28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/sti.79.1.59","volume":"79","author":"SC Kalichman","year":"2003","unstructured":"Kalichman SC, Rompa D. HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy. Sex Transm Infect. 2003;79(1):59\u201361.","journal-title":"Sex Transm Infect"},{"issue":"7","key":"124_CR29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(03)00093-7","volume":"114","author":"JS Tucker","year":"2003","unstructured":"Tucker JS, Burnam MA, Sherbourne CD, Kung F-Y, Gifford AL. Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114(7):573\u201380.","journal-title":"Am J Med"},{"issue":"2","key":"124_CR30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1054773809334958","volume":"18","author":"IB Corless","year":"2009","unstructured":"Corless IB, Lindgren T, Holzemer W, Robinson L, Moezzi S, Kirksey K, et al. Marijuana effectiveness as an HIV self-care strategy. Clin Nurs Res. 2009;18(2):172\u201393.","journal-title":"Clin Nurs Res"},{"issue":"1","key":"124_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00126334-200501010-00008","volume":"38","author":"BC Jong De","year":"2005","unstructured":"De Jong BC, Prentiss D, McFarland W. MAchekano R, Israelski DM. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr. 2005;38(1):43\u20136.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"124_CR32","first-page":"429","volume":"7","author":"P Demas","year":"1995","unstructured":"Demas P, Schoenbaum EE, Wills TA, Doll LS, Klein RS. Stress, coping, and attitudes toward HIV treatment in injecting drug users: a qualitative study. AIDS Educ Prev. 1995;7(5):429\u201342.","journal-title":"AIDS Educ Prev"},{"issue":"5","key":"124_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1521-0391.2003.tb00488.x","volume":"12","author":"MI Rosen","year":"2003","unstructured":"Rosen MI, Rigsby MO, Dieckhaus KD, Cramer JA. Effects of illicit drug use on adherence to prescribed antiretroviral medication. Am J Addict. 2003;12(5):455\u20138.","journal-title":"Am J Addict"},{"issue":"9","key":"124_CR34","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1176\/ajp.149.9.1225","volume":"149","author":"TA Kosten","year":"1992","unstructured":"Kosten TA, Rounsaville BJ. Sensitivity of psychiatric diagnosis based on the best estimate procedure. Am J Psychiatry. 1992;149(9):1225\u20137.","journal-title":"Am J Psychiatry"},{"issue":"9","key":"124_CR35","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/j.1530-0277.2008.00732.x","volume":"32","author":"RS Braithwaite","year":"2008","unstructured":"Braithwaite RS, Conigliaro J, McGinnis KA, Maisto SA, Bryant K, Justice AC. Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls. Alcohol Clin Exp Res. 2008;32(9):1645\u201351.","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"124_CR36","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1086\/522762","volume":"45","author":"M Lazo","year":"2007","unstructured":"Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. Clin Infect Dis. 2007;45(10):1377\u201385.","journal-title":"Clin Infect Dis"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-011-0124-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-011-0124-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-011-0124-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T17:41:56Z","timestamp":1559151716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-011-0124-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["124"],"URL":"https:\/\/doi.org\/10.1007\/s10461-011-0124-7","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,13]]}}}